In Medicare Drug Price Negotiations, Industry Sees Drawbacks And Silver Linings

Drug Pricing Changes Were Top Of Mind At J.P. Morgan

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".